Search results :

Heparin

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: B01AB01, C05BA03, S01XA14

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Alopecia Alopecia postmarketing x x x x x x x x x x x x x x
Asthma Asthma postmarketing x x x x x x x x x x x x x x x
Body temperature increased Body temperature increased postmarketing x x x x x x x x x x x x x x x
Headache Headache postmarketing x x x x x x x x x x x x x x x
Haematoma Haematoma postmarketing x x x x x x x x x x x x x
Haemorrhage Haemorrhage postmarketing x x x x x x x x x x x x x x x
Haemoglobin Haemorrhage postmarketing x x x x x x x x x x x x x x x
Hyperlipidaemia Hyperlipidaemia postmarketing x x x x x x x x x x x x x x
Hypersensitivity Hypersensitivity postmarketing x x x x x x x x x x x x x x x
Nausea Nausea postmarketing x x x x x x x x x x x x x x x
Necrosis Necrosis postmarketing x x
Osteoporosis Osteoporosis postmarketing x x x x x x x x x x x x x x
Pain Pain postmarketing x x x x x x x x x x x x x
Priapism Priapism postmarketing x x x x x x x x x x x x x x
Pruritus Pruritus postmarketing x x x x x x x x x x x x x x x
Rhinitis Rhinitis postmarketing x x x x x x x x x x x x x x x
Shock Shock postmarketing x x x x x x x x x x x x x x x
Ulcer Ulcer postmarketing x x x x x x x x x x x x x
Erythema Erythema postmarketing x x x x x x x x x x x x x x
Urticaria Urticaria postmarketing x x x x x x x x x x x x x x x
Vomiting Vomiting postmarketing x x x x x x x x x x x x x x x
Chills Chills postmarketing x x x x x x x x x x x x x x x
Adrenocortical insufficiency acute Adrenocortical insufficiency acute postmarketing x x x x x x x x x x x x x
Adrenal haemorrhage Adrenal haemorrhage postmarketing x x x x x x x x x x x x x
Retroperitoneal haemorrhage Retroperitoneal haemorrhage postmarketing x x x x x x x x x x x x x
Skin necrosis Skin necrosis postmarketing x x x x x x x x x x x x x x x
Skin exfoliation Skin necrosis postmarketing x x x x x x x x x x x x x x x
Haemorrhage urinary tract Haemorrhage urinary tract postmarketing x x x x x x x x x x x x x x
Anaphylactic shock Anaphylactoid reaction postmarketing x x x x x x x x x x x x x x x
Anaphylactoid reaction Anaphylactoid reaction postmarketing x x x x x x x x x x x x x x x
Lacrimation increased Lacrimation postmarketing x x x x x x x x x x x x x x x
Infection Infection x x x x x
Cyanosis Cyanosis x x x x x x x x x x x x x
Oedema Oedema x
Extravasation Extravasation x x x x x
Gangrene Gangrene x x x x x x
Cardiac failure congestive Cardiac failure congestive x
Hypernatraemia Hypernatraemia x
Myocardial infarction Myocardial infarction x x x x x x
Acute coronary syndrome Myocardial infarction x x x x x x
Phlebitis Phlebitis x x x x x
Cerebrovascular accident Cerebrovascular accident x x x x x x
Thrombocytopenia Thrombocytopenia x x x x x x x x x x x x x x x
Thrombosis Thrombosis x x x x x x x x x
Coagulation time prolonged Coagulation time prolonged x x x x x x x x x x x x x
Heparin-induced thrombocytopenia Heparin-induced thrombocytopenia x x x x x x x x x
Injection site irritation Injection site irritation x x
Fluid retention Water retention x
Fluid overload Fluid overload x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

HEPARIN

Side effects:24
Source:FDA Structured Product Label

HEPARIN

Side effects:27
Source:FDA Structured Product Label

HEPARIN

Side effects:30
Source:FDA Structured Product Label

Heparin

Side effects:29
Source:FDA Structured Product Label

Heparin

Side effects:32
Source:FDA Structured Product Label

Heparin

Side effects:32
Source:FDA Structured Product Label

HEPARIN

Side effects:32
Source:FDA Structured Product Label

Heparin

Side effects:32
Source:FDA Structured Product Label

Heparin

Side effects:33
Source:FDA Structured Product Label

Heparin

Side effects:35
Source:FDA Structured Product Label

HEPARIN

Side effects:37
Source:FDA Structured Product Label

HEPARIN

Side effects:37
Source:FDA Structured Product Label

HEPARIN

Side effects:36
Source:FDA Structured Product Label

HEPARIN

Side effects:36
Source:FDA Structured Product Label

HEPARIN

Side effects:40
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label